Truespan Orthocord
Payments companies reported to CMS as associated with Truespan Orthocord. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Truespan Orthocord, per program year, as reported to CMS.
Who makes it
- Depuy Synthes Sales INC. $70K associated with Truespan Orthocord (2023-2025)
- Medical Device Business Services, INC. $13K associated with Truespan Orthocord (2023-2025)
- Depuy Synthes Products, INC. $1,560 associated with Truespan Orthocord (2023-2025)
- Johnson and Johnson International $1,545 associated with Truespan Orthocord (2023-2025)
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Truespan Orthocord
These are the largest totals companies reported as associated with Truespan Orthocord. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Kyle Borque | Sugar Land, TX | Sports Medicine (Orthopaedic Surgery) | $5,311.65 |
| Patrick Joyner | Naples, FL | Orthopaedic Surgery | $5,302.50 |
| Justin Bartley | Tyler, TX | Sports Medicine (Orthopaedic Surgery) | $1,115.85 |
| Andrew Myerson | La Jolla, CA | Physician Assistant | $710.02 |
| Nathan Skelley | Sioux Falls, SD | Orthopaedic Surgery | $605.00 |
| Leah Brown | San Antonio, TX | Orthopaedic Surgery | $591.96 |
| Daniel Keefe | La Jolla, CA | Orthopaedic Surgery | $565.92 |
| David Kovacevic | New York, NY | Sports Medicine (Orthopaedic Surgery) | $441.28 |
| Joseph Burns | Alpharetta, GA | Sports Medicine (Orthopaedic Surgery) | $439.98 |
| Melissa Martinez | Marietta, GA | Orthopaedic Surgery | $431.40 |
Prescribed Truespan Orthocord?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.